KAYYEM JON FAIZ purchased 1.2% of their position (5K shares) of INHIBRX BIOSCIENCES, INC. on the open market
Open‑market purchase worth $567.6K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/8/2026ACC: 0001366268-26-000004
+5K
Net shares
Net buyer
$567.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+5K
Price / share
$113.52
Trade value
$567.58K
% of position
1.2%
9/8/2026
419.36K→424.36K
Total
Net shares
+5K
Net value
$567.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/8/2026 | P · Purchase | +5K | $113.52 | $567.58K | 1.2% | 419.36K | 424.36K |
| Total | +5K | $567.58K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned69.84K
Common Stock
IndirectShares owned250K
Common Stock
IndirectShares owned250K
Common Stock
IndirectShares owned69.84K
Total
639.69K indirect639.69K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 69.84K | Indirect |
| Common Stock | 250K | Indirect |
| Common Stock | 250K | Indirect |
| Common Stock | 69.84K | Indirect |
| Total | 639.69K | 639.69K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported